HSP90B2P and pancreatic neoplasm: Evaluating the ratio of p-HSP27 to nonphosphorylated HSP before and after chemotherapy is also important because this ratio might be able to determine the boundary between survival and death in gemcitabine-resistance pancreatic cancer cells [20].